| John Dorish Curtis Jr, MD | |
|
975 9th Ave Sw, Suite 300, Bessemer, AL 35022-7837 | |
| (205) 424-1160 | |
| (205) 424-9245 |
| Full Name | John Dorish Curtis Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 18 Years |
| Location | 975 9th Ave Sw, Bessemer, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487622031 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 23005 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical West, An Affiliate Of Uab Health System | Bessemer, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical West Hospital Authority, An Affiliate Of Uab Health System | 6406865427 | 68 |
News Archive
Astellas Pharma Canada, Inc. has announced that it has received approval from Health Canada for a new indication for its topical eczema therapy, Protopic® (tacrolimus ointment 0.03% and 0.1%). The new indication means that tacrolimus ointment can be prescribed for maintenance therapy to prevent flares and prolong flare free intervals in patients with moderate to severe atopic dermatitis (commonly called eczema).
Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the National Cancer Institute.
PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.
A novel radiotherapy approach has shown promise as a treatment option, and may possibly increase the cure rate, for people with early stage lung cancer who are unable to tolerate surgery, according to findings from a five-year study led by SUNY Upstate Medical University.
› Verified 1 days ago
| Entity Name | Medical West Hospital Authority, An Affiliate Of Uab Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952483729 PECOS PAC ID: 6406865427 Enrollment ID: O20061204000666 |
News Archive
Astellas Pharma Canada, Inc. has announced that it has received approval from Health Canada for a new indication for its topical eczema therapy, Protopic® (tacrolimus ointment 0.03% and 0.1%). The new indication means that tacrolimus ointment can be prescribed for maintenance therapy to prevent flares and prolong flare free intervals in patients with moderate to severe atopic dermatitis (commonly called eczema).
Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the National Cancer Institute.
PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.
A novel radiotherapy approach has shown promise as a treatment option, and may possibly increase the cure rate, for people with early stage lung cancer who are unable to tolerate surgery, according to findings from a five-year study led by SUNY Upstate Medical University.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Dorish Curtis Jr, MD 48 Medical Park East Drive, Suite 255, Birmingham, AL 35235 Ph: (205) 838-3090 | John Dorish Curtis Jr, MD 975 9th Ave Sw, Suite 300, Bessemer, AL 35022-7837 Ph: (205) 424-1160 |
News Archive
Astellas Pharma Canada, Inc. has announced that it has received approval from Health Canada for a new indication for its topical eczema therapy, Protopic® (tacrolimus ointment 0.03% and 0.1%). The new indication means that tacrolimus ointment can be prescribed for maintenance therapy to prevent flares and prolong flare free intervals in patients with moderate to severe atopic dermatitis (commonly called eczema).
Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the National Cancer Institute.
PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.
A novel radiotherapy approach has shown promise as a treatment option, and may possibly increase the cure rate, for people with early stage lung cancer who are unable to tolerate surgery, according to findings from a five-year study led by SUNY Upstate Medical University.
› Verified 1 days ago
Dr. Ryan Thomas Cordry, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 975 9th Ave Sw, Ste. 300, Bessemer, AL 35022 Phone: 205-424-1160 Fax: 205-424-9245 |